Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000007028 | SCV000948360 | pathogenic | Congenital myasthenic syndrome 5 | 2022-02-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Glu214*) in the COLQ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COLQ are known to be pathogenic (PMID: 22678886). This variant is present in population databases (rs104893733, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with congenital myasthenic syndrome (PMID: 9689136; 29054425).). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 6649). |
Baylor Genetics | RCV000007028 | SCV005058488 | pathogenic | Congenital myasthenic syndrome 5 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000007028 | SCV000027224 | pathogenic | Congenital myasthenic syndrome 5 | 1998-08-04 | no assertion criteria provided | literature only |